161 related articles for article (PubMed ID: 10890990)
1. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis.
Martel P; Laroche L; Courville P; Larroche C; Wechsler J; Lenormand B; Delfau MH; Bodemer C; Bagot M; Joly P
Arch Dermatol; 2000 Jul; 136(7):881-6. PubMed ID: 10890990
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
3. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.
Bräuninger A; Spieker T; Willenbrock K; Gaulard P; Wacker HH; Rajewsky K; Hansmann ML; Küppers R
J Exp Med; 2001 Oct; 194(7):927-40. PubMed ID: 11581315
[TBL] [Abstract][Full Text] [Related]
4. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus.
Abruzzo LV; Schmidt K; Weiss LM; Jaffe ES; Medeiros LJ; Sander CA; Raffeld M
Blood; 1993 Jul; 82(1):241-6. PubMed ID: 8391875
[TBL] [Abstract][Full Text] [Related]
5. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia.
Matsue K; Itoh M; Tsukuda K; Kokubo T; Hirose Y
Int J Hematol; 1998 Apr; 67(3):319-29. PubMed ID: 9650454
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma.
Ohshima K; Takeo H; Kikuchi M; Kozuru M; Uike N; Masuda Y; Yoneda S; Takeshita M; Shibata T; Akamatsu M
Histopathology; 1994 Dec; 25(6):569-79. PubMed ID: 7698734
[TBL] [Abstract][Full Text] [Related]
7. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
8. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy.
Smith JL; Hodges E; Quin CT; McCarthy KP; Wright DH
Am J Pathol; 2000 Feb; 156(2):661-9. PubMed ID: 10666395
[TBL] [Abstract][Full Text] [Related]
9. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus.
Nakamura S; Sasajima Y; Koshikawa T; Kitoh K; Koike K; Motoori T; Ueda R; Mori S; Suchi T
Pathol Int; 1995 Dec; 45(12):958-64. PubMed ID: 8808302
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features.
Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW
J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776
[TBL] [Abstract][Full Text] [Related]
11. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder.
McNiff JM; Cooper D; Howe G; Crotty PL; Tallini G; Crouch J; Eisen RN
Arch Dermatol; 1996 Dec; 132(12):1464-70. PubMed ID: 8961876
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy.
Schmuth M; Ramaker J; Trautmann C; Hummel M; Schmitt-Gräff A; Stein H; Goerdt S
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):290-5. PubMed ID: 9039203
[TBL] [Abstract][Full Text] [Related]
13. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Jaffe ES; Liu XF; Chen YY; Shibata D; Medeiros LJ
Blood; 1992 Apr; 79(7):1789-95. PubMed ID: 1373088
[TBL] [Abstract][Full Text] [Related]
14. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma].
Li T; Gao D; Zhang B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215
[TBL] [Abstract][Full Text] [Related]
15. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
Foss HD; Anagnostopoulos I; Herbst H; Grebe M; Ziemann K; Hummel M; Stein H
Blood; 1995 May; 85(10):2862-9. PubMed ID: 7742548
[TBL] [Abstract][Full Text] [Related]
16. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
17. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
Weiss LM; Strickler JG; Dorfman RF; Horning SJ; Warnke RA; Sklar J
Am J Pathol; 1986 Mar; 122(3):392-7. PubMed ID: 3082212
[TBL] [Abstract][Full Text] [Related]
18. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.
Feller AC; Griesser H; Schilling CV; Wacker HH; Dallenbach F; Bartels H; Kuse R; Mak TW; Lennert K
Am J Pathol; 1988 Dec; 133(3):549-56. PubMed ID: 2849301
[TBL] [Abstract][Full Text] [Related]
19. Clonal T cell population in angioimmunoblastic lymphadenopathy and related lesions.
Suzuki H; Namikawa R; Ueda R; Obata Y; Suchi T; Kikuchi M; Ota K; Takahashi T
Jpn J Cancer Res; 1987 Jul; 78(7):712-20. PubMed ID: 3114197
[TBL] [Abstract][Full Text] [Related]
20. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma.
Lipford EH; Smith HR; Pittaluga S; Jaffe ES; Steinberg AD; Cossman J
J Clin Invest; 1987 Feb; 79(2):637-42. PubMed ID: 3805286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
